Sort
64,565 grants matching “drug discovery”
Targeted Discovery of Marine-derived Anticancer Leads
$1,100,018Phil Crews · University Of California Santa Cruz · U19 · FY2009 · CA
Preclinical and early clinical development of a GABA-A a5 PAM
$1,100,000Kenneth G Payie · Agenebio, Inc. · U01 · FY2024 · AG
DCTD Preclinical In Vivo/In Vitro Assay Development
$1,100,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Center for Systems Analysis of the Cancer Regulome
$1,100,000Ilya Shmulevich · Institute For Systems Biology · U24 · FY2014 · CA
Preclinical and early clinical development of a GABA-A a5 PAM
$1,100,000Sharon Rosenzweig-Lipson · Agenebio, Inc. · U01 · FY2022 · AG
Kinetics-Driven Drug Discovery Using Persistent Homology, Rare-Event Molecular Dynamics and Experimental Data
$1,100,000Alex Dickson · Michigan State University · · FY2018 · MPS
Case GI SPORE
$1,100,000Sanford D Markowitz · Case Western Reserve University · P50 · FY2016 · CA
Preclinical and early clinical development of a GABA-A a5 PAM
$1,100,000Sharon Rosenzweig-Lipson · Agenebio, Inc. · U01 · FY2023 · AG
Center for Systems Analysis of the Cancer Regulome
$1,100,000Ilya Shmulevich · Institute For Systems Biology · U24 · FY2009 · CA
Center for Undiagnosed Diseases at Stanford
$1,100,000Euan A Ashley · Stanford University · U01 · FY2021 · HG
University of Michigan MPED & PMDI Ped Med Device Consortium
$1,100,000James D Geiger · University Of Michigan At Ann Arbor · P50 · FY2011 · FD
Translating innovative research discoveries to a potential therapeutic for Down S
$1,100,000Elizabeth Keith Messersmith · Balance Therapeutics, Inc. · U44 · FY2012 · NS
Coordinating Center for the Drug Induced Liver Injury Network (DILIN)
$1,100,000Huiman X Barnhart · Duke University · U24 · FY2018 · DK
Center for Undiagnosed Diseases at Stanford
$1,100,000Euan A Ashley · Stanford University · U01 · FY2020 · HG
Assembly and export of mycobacterial lipoglycans
$1,099,930Mary Jackson · Colorado State University · R01 · FY2025 · AI
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,099,920Claire F Verschraegen · Ohio State University · UG1 · FY2020 · CA
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,099,919Claire F Verschraegen · Ohio State University · UG1 · FY2019 · CA
Tissue Chip Modeling of Synovial Joint Pathologies: Effects of Inflammation and Adipose-Mediated Diabetic Complications
$1,099,608Hang Lin · University Of Pittsburgh At Pittsburgh · UH3 · FY2020 · TR
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,099,568Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2019 · CA
Development of Wnt Pathway Inhibitors for Colorectal Cancer
$1,099,566Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2012 · CA
Oncogenic Kinases in Cancer
$1,099,330John Brognard · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Optimization of efflux avoidance and inhibition for antibiotic development
$1,099,291Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2022 · AI
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,099,106Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Interdisciplinary Approach to Alzheimer Drug Discovery
$1,099,042Thomas Jefferson University · P01 · FY2005 · AG
A complete map of the top 100 molecules from the gut microbiome
$1,099,000Michael Andrew Fischbach · Stanford University · DP1 · FY2017 · DK